Clindamycin Injection, Solution
Product Images NDC 71872-7199

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 71872-7199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7199-1.pdp (71872 7199 1)

71872-7199-1.pdp (71872 7199 1)
This is a pharmacy bulk package of Clindamycin Injection for intravenous use, with 9,000mg per 60mL. It is not intended to be dispensed as a unit and must be diluted before IV use. It is sterile with non-pyrogenic contents, and contains Clindamycin phosphate equivalent to Clindamycin 150mg of Clindamycin. The package insert should be consulted for dosage information. The bulk package is intended for preparing many single doses in a pharmacy admixture program, and further dilution is required. The product should be discarded within 4 hours of initial entry and should be stored at a temperature of 20° to 25°C. There is additional information on the insert. The product has been repackaged and distributed by Medical Purchasing Solutions.*
FDA Label Image

Structural Formula (Cli05 0002 01)

FDA Label Image

Package Label – Principal Display Panel – Bottle Label (Cli05 0002 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.